Utility of urinary circulating tumor DNA for EGFR mutation detection in different stages of non-small cell lung cancer patients

被引:0
|
作者
Fajiu Li
Jie Huang
Dongyuan Ji
Qinghua Meng
Chuanhai Wang
Shi Chen
Xiaojiang Wang
Zhiyang Zhu
Cheng Jiang
Yi Shi
Shuang Liu
Chenghong Li
机构
[1] Wuhan No. 6 Hospital,Department of Respiratory Medicine
[2] Affiliated Hospital to Jianghan University,undefined
来源
关键词
Non-small-cell lung cancer; Urinary cell free DNA; EGFR mutations; Treatment monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1283 / 1291
页数:8
相关论文
共 50 条
  • [21] Detection of circulating tumor cells in non-small cell lung cancer
    Hanssen, Annkathrin
    Loges, Sonja
    Pantel, Klaus
    Wikman, Harriet
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [22] Cell-Free Tumor DNA (ctDNA) Utility in Detection and Monitoring EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, J.
    Kasymjanova, G.
    Papadakis, A.
    Small, D.
    Sakr, L.
    Pepe, C.
    Wang, H.
    Cohen, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1035 - S1035
  • [23] Detection of EGFR alterations in circulating tumor DNA of non-small cell lung cancer by digital PCR and Next Generation Sequencing
    Malpeli, G.
    Simbolo, M.
    Pilotto, S.
    Lawlor, R. T.
    Peretti, U.
    Bonizzato, G.
    Kinspergher, S.
    Ferrara, R.
    Cantu, C.
    Caccese, M.
    Tortora, G.
    Bria, E.
    Scarpa, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 79 - 79
  • [24] CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
    Peng, Hao
    Lu, Lan
    Zhou, Zisong
    Liu, Jian
    Zhang, Dadong
    Nan, Kejun
    Zhao, Xiaochen
    Li, Fugen
    Tian, Lei
    Dong, Hua
    Yao, Yu
    GENES, 2019, 10 (11)
  • [25] Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing
    Diehn, M.
    Bratman, S. V.
    Newman, A. M.
    Neal, J. W.
    Wakelee, H. A.
    Merritt, R. E.
    Shrager, J. B.
    Loo, B. W.
    Alizadeh, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S75 - S75
  • [26] The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer
    Lin, Xiao
    Dong, Wentao
    Lai, Xiaojing
    Feng, Wei
    Yu, Xiaofu
    Gu, Qing
    Wang, Chunyang
    Xiao, Wen
    Zheng, Xiao
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 170 - 179
  • [27] Circulating Tumor DNA for Noninvasive Monitoring of Non-Small Cell Lung Cancer Patients Receiving EGFR-Targeted Therapies
    Tsui, Dana
    Muhammed, Murtaza
    Wong, Alvin S. C.
    Rueda, Oscar M.
    Forshew, Tim
    Soo, Ross
    Wong, H. I.
    Goh, Boon Cher
    Eisen, Tim
    Marass, Francesco
    Gale, Davina
    Liu, Wei
    Chin, Tan Min
    Rosenfeld, Nitzan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S358 - S359
  • [28] Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer
    Wan, Rui
    Wang, Zhijie
    Lee, J. Jack
    Wang, Shuhang
    Li, Qingqing
    Tang, Fuchou
    Wang, Jin
    Sun, Yu
    Bai, Hua
    Wang, Di
    Zhao, Jun
    Duan, Jianchun
    Zhuo, Minglei
    An, Tongtong
    Wu, Meina
    Chen, Zhaoli
    Yang, Zhenlin
    Wang, Jie
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1376 - 1387
  • [29] Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer
    Lazzari, Chiara
    Gregorc, Vanesa
    Cangi, Maria Giulia
    Giovannetti, Elisa
    Bulotta, Alessandra
    Santarpia, Mariacarmela
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4023 - S4027
  • [30] EGFR mutation profile in Australian patients with non-small cell lung cancer
    Mead, Scott
    Lucas, Mark
    Pang, Jia-Min
    Fellowes, Andrew
    Harraway, James
    Svobodova, Suzanne
    Amanuel, Benhur
    Fox, Stephen
    PATHOLOGY, 2021, 53 (07) : 933 - 936